InMode Ltd. Ordinary Shares

INMD

InMode Ltd. is a medical technology company specializing in minimally invasive aesthetic and medical treatment solutions. The company's devices utilize radio-frequency technology to deliver non-invasive procedures for body contouring, skin tightening, and other dermatological applications. Founded in 2001 and headquartered in Israel, InMode's products are used by medical and cosmetic practitioners worldwide to offer safer, more efficient treatments.

$15.47 -0.34 (-2.15%)
🚫 InMode Ltd. Ordinary Shares does not pay dividends

Company News

Energy-Based Aesthetic Devices Market Research Report 2026-2031: Advancements in Laser and RF Systems, Rising Consumer Demand and Geographic Expansion Accelerate Revenue Opportunities
GlobeNewswire Inc. • Researchandmarkets.Com • February 17, 2026

The Energy-Based Aesthetic Devices Market is projected to grow from USD 7.03 billion in 2025 to USD 11.80 billion by 2031 at a CAGR of 9.02%. Growth is driven by increased demand for hair removal treatments, med-spa expansion, minimally invasive procedures, and AI integration. Laser-based technology dominates the market, with North America leadin...

Deal Dispatch: Musk Merger Talk, LIV Golf Stakes, And A Flurry Of M&A From AI To Athleisure
Benzinga • Anthony Noto • January 30, 2026

Major M&A activity spans multiple sectors: Elon Musk reportedly weighs merging SpaceX, Tesla, and xAI; C3.ai is in merger talks with Automation Anywhere; Anta Sports acquires 29% stake in Puma for €1.51 billion; Steel Partners offers $1.1 billion for InMode controlling stake; LIV Golf seeks minority investors for team stakes; and First Brands G...

Steel Partners Targets InMode, Citing Stock Underperformance
Benzinga • Vandana Singh • January 29, 2026

Steel Partners Holdings has made an unsolicited proposal to acquire a controlling 51% stake in InMode Ltd. at $18 per share, representing a 29% premium to the stock's January 23 closing price. The acquisition proposal cites InMode's poor stock performance (negative 19.18% over one year), repeated guidance cuts (seven reductions in nine quarters),...

InMode to Participate in Upcoming Investor Conferences
Benzinga • Prnewswire • August 5, 2025

InMode Ltd. announced participation in two investor conferences in August 2025, including the Needham Virtual MedTech & Diagnostics Conference and Canaccord 45th Annual Global Growth Conference, featuring presentations by their CEO and CFO.

[Latest] Global Cosmetic Surgery Market Size/Share Worth USD 207.6 Billion by 2033 at a 11.7% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
GlobeNewswire Inc. • Custom Market Insights • January 31, 2025

The global cosmetic surgery market is expected to grow from $67.2 billion in 2023 to $207.6 billion by 2033, at a CAGR of 11.7%. The market is driven by the growing acceptability and desire for less invasive treatments, with surgical procedures and the female segment holding the highest market share.

Related Companies